Pipeline

Product
Indications
Stage of Development
Lead Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Front of Eye
(tyrosine kinase inhibitor; 505(B)(2))
Pterygium
(FPR agonist; in-licensed)
Dry Eye
Other Ocular
Inflammation Diseases
Back of Eye
(anti-VEGF + disintegrins)
DME
wAMD
Other Retinal
Diseases
Disintegrin Platform
Other Retinal
Diseases
Product
Front of Eye
(tyrosine kinase inhibitor; 505(B)(2))
Stage of Development
Lead Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Indications
Pterygium
Product
(FPR agonist; in-licensed)
Stage of Development
Lead Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Indications
Dry Eye
Indications
Other Ocular
Inflammation Diseases
Product
Back of Eye
(anti-VEGF + disintegrins)
Stage of Development
Lead Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Indications
DME
Indications
wAMD
Indications
Other Retinal Diseases
Product
Disintegrin Platform
Stage of Development
Lead Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Indications
Other Retinal Diseases